Compare · DXCM vs MOBI

DXCM vs MOBI

Side-by-side comparison of DexCom Inc. (DXCM) and Mobia Medical Inc. (MOBI): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both DXCM and MOBI operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • DXCM is the larger of the two at $29.91B, about 75.7x MOBI ($395.3M).
  • DXCM has been more active in the news (15 items in the past 4 weeks vs 5 for MOBI).
  • DXCM has more recent analyst coverage (25 ratings vs 0 for MOBI).
MetricDXCMMOBI
Company
DexCom Inc.
Mobia Medical Inc.
Price
-
-
Market cap
$29.91B
$395.3M
1M return
-
+24.22%
1Y return
-
+1.74%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NASDAQ
IPO
2005
2026
News (4w)
15
5
Recent ratings
25
0
DXCM

DexCom Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

MOBI

Mobia Medical Inc.

Mobia Medical, Inc. is a medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company's Vivistim® Paired VNS System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.

Latest DXCM

Latest MOBI